On-time Enrollment Feasibility


The upfront investment of time and medical expertise into each feasibility assessment underlies PSI’s patient enrollment success in clinical trials.

For the majority of studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience to determine the best sites and countries for each study.

We give every project a thorough assessment through our dedicated, full-time Feasibility Department.  Our dedicated professionals determine clinical trial feasibility for each of the following criterion:

  • Medical feasibility
  • Clinical feasibility
  • Logistical feasibility
  • Regulatory feasibility

With people located in 11 countries throughout North America, Europe, Asia, and Latin America being led by our team of internal medical doctors, laboratory experts, imaging specialists, logisticians, pharmacy and regulatory experts, PSI predicts accurate dates for the enrollment of the first and last patients.

In recent years, our specialists have conducted over 2,000+ feasibility assessments for studies in 50+ countries.  These assessments cover, but are not restricted to, evaluation of the target population availability and factors that limit it, standards of care, competitive studies, regulatory climates and the need to engage particular Key Opinion Leaders into the study.  We weigh all of these factors before making recommendations.

Our value-added feasibility assessments for regional or global programs provide our sponsors with the best choice of sites and geography, ensuring predictable and accurate enrollment projections.

Please contact PSI to learn how the accuracy of feasibility can help you achieve your study goals.

Contact PSI


Outsourcing in Clinical Trials Southern California
October 14-15, 2015, La Jolla, CA
Visit the Site  
View More


“Successful completion of patient recruitment in just over 12 months is a credit to the clinical team which has worked tirelessly to execute this trial within the tight timeline and budget”
Chief Scientific Officer, Australia February 2013
“I’m always impressed with how PSI employees conduct themselves and I frequently hear them say …”that is not a problem” no matter how big or small the request may be.”
Director Clinical Operations US January 2013
"PSI team, we got [drug] approved in US! This would not have been possible without all your efforts and your help. I wanted to thank all of you for this!”
Clinical Project Manager Austria June 2013
Read More



Zug, Switzerland, September 8, 2015 – PSI CRO, a full-service contract research organization, also known as the #Antibiotic Powerhouse as pronounced by one of many of its infectious disease customers, announced today that they will, of course, be attending the upcoming ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) in San Diego, … Read More »

Read More


  • This field is for validation purposes and should be left unchanged.